1-3 of 3
Authors: L Dyal
Journal Article
Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial Free
European Heart Journal, Volume 41, Issue Supplement_2, November 2020, ehaa946.3353, https://doi.org/10.1093/ehjci/ehaa946.3353
Published: 25 November 2020
Journal Article
2180Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial Get access
European Heart Journal, Volume 40, Issue Supplement_1, October 2019, ehz748.0099, https://doi.org/10.1093/eurheartj/ehz748.0099
Published: 21 October 2019
Journal Article
Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF/IGT with a recent myocardial infarction Get access
European Heart Journal, Volume 34, Issue suppl_1, 1 August 2013, 1966, https://doi.org/10.1093/eurheartj/eht308.1966
Published: 01 August 2013
